European Medicines Agency "AstraZeneca Applies for COVID-19 Vaccine Approval"

At Churchill Hospital in Oxford, southern England, UK, on the 4th (local time), 82-year-old Brian Pinker received the COVID-19 vaccine jointly developed by Oxford University and AstraZeneca from nurse Sam Foster. Pinker was recorded as the first recipient of the AstraZeneca vaccine. A former mechanic and kidney disease patient, he expressed joy, saying, "I can now look forward to celebrating our 48th wedding anniversary this year."

On the 12th (local time), the European Medicines Agency (EMA) announced that the multinational pharmaceutical company AstraZeneca has submitted an application for conditional marketing authorization for its COVID-19 vaccine.

EMA added that discussions on the approval of this vaccine will take place by the 29th, when the EMA expert committee meeting is scheduled.

Previously, EMA recommended conditional marketing authorization for the COVID-19 vaccines jointly developed by the American pharmaceutical company Pfizer and the German company BioNTech, as well as the COVID-19 vaccine developed by the American company Moderna.

Accordingly, the European Union (EU) has approved the use of these two vaccines within EU member states.

This content was produced with the assistance of AI translation services.